Search
Synthetic Opioids: Navigating a Changing Landscape in the Treatment of Opioid Use Disorder
Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes
Background
Opioid overdose remains a public health crisis in diverse communities. Between 2019 and 2020, there was an almost 40% increase in drug fatalities primarily due to opioid analogues of both stimulants and opioids. Medications for...
High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder
In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of...
A US national randomized study to guide how best to reduce stigma when describing drug‐related impairment in practice and policy
Best Practices for Successful Reentry for People Who Have Opioid Addictions
Mindful Body Awareness Training as Part of Treatment for Substance Use Disorder
Addiction 101

The Recovery Research Institute have developed a new website that aims to answer the most common questions asked about addiction.
Addiction 101 addresses questions such as:
- What is the prevalence and cause of addiction?
- What does...
The Link between the Marketing of Opioid Products with Mortality from Opioid-Related Overdoses
Efficacy of Monthly Buprenorphine Injections for Opioid Use Disorders
Opioid use disorder is a chronic, relapsing disease and a global health burden. Treatment for OUD tends to involve a combination of medication and behavioural intervention. It is recognised that buprenorphine can alleviate opioid withdrawal...
Risk Factors for Neonatal Abstinence Syndrome
Recent studies carried out by researchers from Vanderbilt University and Johns Hopkins University have examined characteristics linked with the heightened risk NAS.
The researchers found that boys are more likely to receive a diagnosis of...
Field Guide to Drug Demand Reduction Program Development, 3rd ed.
The Field Guide to Drug Demand Reduction (DDR) Program Development is an annual publication by the U.S. Department of State primarily for its Embassy personnel abroad to guide in the development of substance use prevention and treatment...
Risk Factors for Discontinuation of Treatment for Opioid Use Disorders
Opioid Use Disorder (OUD), and the associated risk of overdose and death, is becoming one of the most prevalent threats to health and social wellbeing in the United States. Medication, such as buprenorphine, is the gold standard treatment...
Buscar Tratamiento de Calidad para Trastornos de Uso de Sustancias
Esta hoja informativa se puede usar como una guía para las personas que buscan tratamiento de salud mental. Ofrece tres pasos necesarios para llevar a cabo antes de utilizar un centro de tratamiento, así como las cinco señales de un centro...
Webinar: Treatment and Prevention of Opioid Use Disorder: Overview
A webinar on opioid use disorder by Dr. Dennis McCarty is now available through the Addiction Technology Transfer Centre (ATTC) website.
The hour long webinar took place in April 2018 and discusses treatment and prevention. The webinar...
SAMHSA Tobacco-Free Recovery Grant 2018
The Substance Abuse and Mental Health Services Administration (SAMHSA) National Center of Excellence for Tobacco-Free Recovery Grant is now open for applications. Offering up to 5 million USD the grant can be used for a range of projects...
Annual Surveillance Report of Drug-Related Risks and Outcomes
This report presents information on four types of outcomes from the four different data sources:
- Opioid prescribing, 2006-2016, from QuintilesIMS Health®
- Drug use, misuse, and substance use disorder, 2014-2015, from the National Survey...
Association between Receptivity to Tobacco Advertising and Progression to Tobacco Use in Youth and Young Adults
A study funded by the National Institute on Drug Abuse (NIDA) has found an association with young people being exposed to adverts for electronic cigarettes (e-cigarettes) and taking up smoking later in life.
The study followed 10 989...
Medication for the Treatment of Alcohol Use Disorder
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), the Health and Human Services US Government Department (HSS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) have collaborated to create a manual on...
New Resource Centre from SAMHSA
SAMHSA has launched the new Evidence Based Resource Center which will allow practitioners to find tools, manuals, clinical practice guidelines and science based-resources.
Available directly through the SAMHSA website, the digital...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member